Know Cancer

or
forgot password

An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus (HPV) Types in Women >= 18 Years of Age, in Egypt


N/A
18 Years
N/A
Not Enrolling
Female
Human Papillomavirus Infection

Thank you

Trial Information

An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus (HPV) Types in Women >= 18 Years of Age, in Egypt


Inclusion Criteria:



- Women >= 18 years of age attending a clinic for gynaecological examination.

- Women who agree to provide a cervical sample for human papillomavirus testing.

- Written informed consent obtained from the subject.

Exclusion Criteria:

- Referral for abnormal cervical sample at the current visit.

- Abundant menstrual bleeding or vaginal discharge not allowing appropriate screening
to be performed.

- History of hysterectomy.

- Known diagnosis of immunosuppression, or patient on immunosuppressives.

- Pregnant women.

- Having received one or more doses of HPV vaccine prior to participating in the study.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Occurrence of Human papillomavirus (HPV) DNA and of any of the HPV types among women undergoing cervical sample testing.

Outcome Time Frame:

Average timeframe: 12 months

Safety Issue:

No

Principal Investigator

GSK Clinical Trials

Investigator Role:

Study Director

Investigator Affiliation:

GlaxoSmithKline

Authority:

Egypt: Ministry of Health

Study ID:

113367

NCT ID:

NCT01158209

Start Date:

October 2010

Completion Date:

August 2011

Related Keywords:

  • Human Papillomavirus Infection
  • Warts
  • Papillomavirus Infections

Name

Location